NCT04101149Active, not recruiting
Genetic Causes of Familial Hypercholesterolemia
Genetiska Orsaker Till familjär Hyperkolesterolemi- Mekanism, Prognos Och Individanpassad Behandling
Source: ClinicalTrials.gov · Last updated 8 Apr 2025
Brief summary (registry, in English)
Familial hypercholesterolemia (FH) is a common disease. The genetic background to FH is not yet fully understood. In the present prospective cohort study we aim to study the association between different clinical characteristics, gene mutations and prognosis.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 150 (estimated)
- First submitted
- 20 Sept 2019
- Start date
- 1 Sept 2019
- Primary completion date
- 31 Dec 2025
- Lead sponsor
- Region Örebro County
- Diseases
- Familial hypercholesterolaemia
- NCT number
- NCT04101149
What you commit to
- Study type: Observational
- Planned participants: 150
- From 1 Sept 2019 to the primary completion date, 31 Dec 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Age
- 1\) Age below 8 years.
Who the study is looking for
- Age 8 years or older.
- Clinical suspicion of FH
- Dutch Lipid Clinic Network Score of at least four or a first grade relative with a genetic deviation that may be associated with FH.
Age in the registry: 8 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Örebro University Hospital Coordinator of this site? Confirm its status | Örebro | Sweden | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.